US · CAL · APPAREL - RETAIL
Caleres, Inc. (CAL) intrinsic value and stock valuation
$11.81as of 2026-11-21 · Mkt cap 487.05M
Data updated · price as of 2026-11-21
- P/E
- Pro
- P/B
- Pro
- P/S
- Pro
Price history
Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.
Caleres, Inc. DCF and intrinsic value
InvestorsCraft values CAL with the Chepakovich two-stage DCF model — currently rated strongly undervalued. How the model works · Run your own DCF prefilled from CAL’s statements →
Caleres, Inc. Graham Number
The Graham Number is not defined for negative earnings or book value. Guide · Calculator →
How the business is doing
Fiscal 2012–2026, USD
Is it expensive?
Each multiple against its own 15-year range, or against peers where no history is available
Peers
Same-industry companies, ranked by market cap
Peer comparison
The peer comparison table is shown only to users with a Pro subscription.
Financials
Statements by fiscal year
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Revenue | $2.76B | $2.72B | $2.82B | $2.97B | $2.78B |
| Operating income | $29M | $149.9M | $201.3M | $214.3M | $205.8M |
| Net income | -$-7.05M | $107.3M | $163.9M | $181.7M | $137M |
| EPSd | -$-215.99K | $3.2M | $4.8M | $5.13M | $3.69M |
| Operating cash flow | $100.3M | $104.6M | $200.2M | $125.9M | $168.4M |
| Capital expenditure | -$-67.89M | -$-49.15M | -$-49.62M | -$-64.04M | -$-24.14M |
| Free cash flow | $32.4M | $55.4M | $150.5M | $61.8M | $144.3M |
| Total assets | $1.97B | $1.89B | $1.8B | $1.84B | $1.84B |
| Total debt | $891.1M | $826.6M | $747.9M | $887.6M | $871.4M |
| Net debt | $861.4M | $796.9M | $726.5M | $853.9M | $841.3M |
| Total equity | $609M | $606M | $567.6M | $426.1M | $323.4M |
| Cash and short-term investments | $29.8M | $29.6M | $21.4M | $33.7M | $30.1M |
Income statement
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Revenue | $2.76B | $2.72B | $2.82B | $2.97B | $2.78B |
| Cost of revenue | $1.57B | $1.5B | $1.55B | $1.68B | $1.55B |
| Gross profit | $1.18B | $1.22B | $1.26B | $1.28B | $1.23B |
| Research and development expenses | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Selling, general and administrative expenses | $1.16B | $1.07B | $1.06B | $1.07B | $1.01B |
| Other expenses | $0.00 | $7.17M | $6.85M | $0.00 | $13.5M |
| Operating expenses | $1.16B | $1.07B | $1.06B | $1.07B | $1.02B |
| Cost and expenses | $2.74B | $2.57B | $2.62B | $2.75B | $2.57B |
| Interest income | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest expense | $18.5M | $14M | $19.3M | $14.3M | $30.9M |
| Depreciation and amortization | $64.6M | $56.4M | $53.3M | $49M | $52.3M |
| Ebitda | $70.8M | $205.5M | $253.9M | $276.3M | $257.1M |
| Operating income | $29M | $149.9M | $201.3M | $214.3M | $205.8M |
| Total other income/expenses, net | $0.00 | -$-14.7M | -$-19.98M | -$-1.29M | -$-16.56M |
| Income before tax | -$-12.22M | $135.2M | $181.3M | $213M | $189.2M |
| Income tax expense | -$-2.35M | $29.1M | $9.49M | $33.3M | $51.1M |
| Net income | -$-7.05M | $107.3M | $163.9M | $181.7M | $137M |
| Weighted average shares outstanding | $32.5M | $33.4M | $34.1M | $34.9M | $36.7M |
| Weighted average diluted shares outstanding | $32.6M | $33.5M | $34.2M | $35.4M | $37.1M |
Balance sheet
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Cash and short-term investments | $29.8M | $29.6M | $21.4M | $33.7M | $30.1M |
| Net receivables | $152.7M | $169.6M | $154.6M | $150.3M | $155.3M |
| Inventory | $610.5M | $565.2M | $540.7M | $580.2M | $596.8M |
| Total current assets | $862.8M | $836.5M | $788.9M | $831.5M | $836.5M |
| Property, plant and equipment, net | $765.3M | $581.1M | $695.6M | $679.1M | $653.7M |
| Goodwill and intangible assets | $204.2M | $192.3M | $203.3M | $215.4M | $227.5M |
| Long-term investments | $0.00 | $0.00 | $32.7M | $0.00 | -$-14.73M |
| Total non-current assets | $1.1B | $1.06B | $1.02B | $1.01B | $1.01B |
| Total assets | $1.97B | $1.89B | $1.8B | $1.84B | $1.84B |
| Accounts payable | $191.2M | $237M | $251.9M | $229.9M | $331.5M |
| Short-term debt | $423.5M | $347M | $294.8M | $443.6M | $418.5M |
| Deferred revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total current liabilities | $845.5M | $757.9M | $743M | $911.2M | $1.03B |
| Long-term debt | $467.6M | $479.5M | $453.1M | $444.1M | $905.8M |
| Deferred revenue, non-current | $0.00 | $0.00 | $0.00 | $0.00 | -$-14.73M |
| Total non-current liabilities | $511.3M | $530.9M | $494.2M | $499.2M | $494.9M |
| Capital lease obligations | $594.6M | $607.1M | $565.9M | $580.1M | $581.4M |
| Total liabilities | $1.36B | $1.29B | $1.24B | $1.41B | $1.52B |
| Common stock | $340K | $340K | $350K | $360K | $380K |
| Retained earnings | $421.2M | $442.4M | $410.3M | $266.3M | $158M |
| Accumulated other comprehensive income (loss) | -$-18.58M | -$-34.02M | -$-34.5M | -$-26.75M | -$-8.61M |
| Total equity | $609M | $606M | $567.6M | $426.1M | $323.4M |
| Total investments | $0.00 | $0.00 | $32.7M | $0.00 | -$-14.73M |
| Total debt | $891.1M | $826.6M | $747.9M | $887.6M | $871.4M |
| Net debt | $861.4M | $796.9M | $726.5M | $853.9M | $841.3M |
Cash flow statement
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Net income | -$-6.69M | $106.1M | $163.9M | $179.7M | $138.2M |
| Depreciation and amortization | $64.6M | $56.4M | $53.3M | $49M | $52.3M |
| Stock-based compensation | $12.4M | $15.1M | $14.8M | $17.3M | $12.3M |
| Change in working capital | $34M | -$-94.8M | -$-31.43M | -$-126.17M | -$-14.19M |
| Accounts receivable | $16.3M | -$-15.61M | -$-8.49M | -$-10.3M | $7M |
| Inventory | $37.8M | -$-23.29M | $39.5M | $16.2M | -$-108.77M |
| Accounts payable | -$-51.75M | -$-14.36M | $22M | -$-101.45M | $50.9M |
| Net cash provided by operating activities | $100.3M | $104.6M | $200.2M | $125.9M | $168.4M |
| Investments in property, plant and equipment | -$-67.89M | -$-49.15M | -$-44.58M | -$-64.04M | -$-24.14M |
| Acquisitions, net | -$-90.94M | $0.00 | $0.00 | $3.14M | $0.00 |
| Net cash used for investing activities | -$-158.83M | -$-51.69M | -$-49.62M | -$-64.04M | -$-24.14M |
| Common stock issued | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common stock repurchased | -$-8.91M | -$-65.04M | -$-17.45M | -$-63.23M | -$-16.96M |
| Dividends paid | -$-9.45M | -$-9.69M | -$-9.95M | -$-10.18M | -$-10.65M |
| Net cash used for financing activities | $58.7M | -$-44.51M | -$-162.99M | -$-58.15M | -$-202.38M |
| Net change in cash | $130K | $8.28M | -$-12.34M | $3.58M | -$-58.18M |
| Cash at end of period | $29.8M | $29.6M | $21.4M | $33.7M | $30.1M |
| Operating cash flow | $100.3M | $104.6M | $200.2M | $125.9M | $168.4M |
| Capital expenditure | -$-67.89M | -$-49.15M | -$-49.62M | -$-64.04M | -$-24.14M |
| Free cash flow | $32.4M | $55.4M | $150.5M | $61.8M | $144.3M |
Line items
Line items
Line items
About Caleres, Inc.
Caleres, Inc. is a long-standing company primarily involved in the design, sourcing, retail, and wholesale distribution of various footwear products. Its operations span the United States, Canada, China, and Guam, organized into two main divisions: Famous Footwear and Brand Portfolio. The company's comprehensive product range includes athletic, casual, and dress footwear available under licensed, proprietary, and private-label brands, catering to women, men, and children. Through its numerous retail shoe stores, Caleres offers customers a wide selection of popular brand-name shoes from leading manufacturers like Nike, Skechers, adidas, and Dr. Martens. This is complemented by a substantial portfolio of company-owned and licensed brands such as Dr. Scholl's Shoes, Blowfish Malibu, LifeStride, Naturalizer, Franco Sarto, and Ryka. Beyond its physical storefronts, Caleres maintains a significant digital presence, managing a multitude of brand-specific e-commerce websites including naturalizer.com, samedelman.com, allenedmonds.com, and many others. The company also plays a crucial role in the broader footwear supply chain, engaging in the design, sourcing, manufacturing, and marketing of footwear to a diverse client base. This includes national chains, online retailers, department stores, mass merchandisers, independent retailers, and catalog businesses. Its wholesale division additionally distributes men's apparel, leather goods, and accessories under the Allen Edmonds brand, as well as specialized women's footwear lines such as LifeStride, Italian footwear by Franco Sarto, athletic shoes from Rykä, and collections from Vince, Bzees, Zodiac, Veronica Beard, and Via Spiga. With approximately 980 retail locations, the company has a strong market footprint. Founded in 1878 and formerly known as Brown Shoe Company, Inc., Caleres, Inc. is headquartered in St. Louis, Missouri.
- CEO
- John W. Schmidt
- Employees
- 10K
- Beta
- 0.76
Included in
Explore
Frequently asked questions
What is the intrinsic value of Caleres, Inc. (CAL)?
Caleres, Inc. (CAL) is currently strongly undervalued based on the InvestorsCraft IC model — IC value is more than 50% above the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.
Is CAL undervalued?
CAL trades at a price of $11.81 (Nov 21, 2026): strongly undervalued — IC value is more than 50% above the price.
How is the intrinsic value calculated?
InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.
How often is this page updated?
Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.